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Abstract Adaptation to hypoxia is essential for tumor progres-
sion. Transcriptional activation of hypoxia-regulated genes is
mediated by hypoxia-inducible factor 1 (HIF-1), a heterodimer
of HIF-1K and ARNT (Ah receptor nuclear translocator; HIF-
1L). Using representational di¡erence analysis, we identi¢ed
three novel hypoxia-inducible genes: MIG-6 (gene 33), adipo-
philin and tuftelin. The mRNAs for these genes were inducible
by 1% O2 in the human HepG2 and MCF-7 cell lines. Hypoxic
induction of the MIG-6 and tuftelin proteins was also observed.
Induction was ARNT-dependent. Induction also occurred in liv-
ers of mice treated with CoCl2, which mimics hypoxia. The
potential roles of these genes in adaptation to hypoxia and in
tumorigenesis will be of considerable interest.
2 2002 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Mammalian cells respond to low oxygen levels in part by
eliciting adaptive changes in gene expression. This complex
response involves numerous genes with diverse biological
functions. In general, these adaptive responses help to estab-
lish oxygen homeostasis in oxygen-de¢cient tissues by increas-
ing O2 delivery (erythropoiesis, and angiogenesis) or by pro-
viding metabolic adaptation to reduced O2 availability
(glycolysis). Transcriptional activation of most hypoxia-re-
sponsive genes is mediated by hypoxia-inducible factor 1
(HIF-1), which is a heterodimer of two basic helix^loop^helix
(bHLH)-Per^Arnt^Sim (PAS) proteins, HIF-1K and ARNT
(aryl hydrocarbon receptor nuclear translocator; also termed
HIF-1L) [1]. ARNT also heterodimerizes with several other
bHLH-PAS proteins. For example, it dimerizes with the Ah
receptor (AHR), thereby regulating the transcription of a
number of genes involved in metabolism of carcinogens and
other xenobiotics [2]. The expression of ARNT protein is
maintained at constant levels in normoxic and hypoxic cells.
In contrast to ARNT, the HIF-1K subunit is unique to
HIF-1, and its expression and activity are tightly regulated
by cellular O2 concentration [3]. HIF-1K regulation occurs
at multiple levels including mRNA expression, protein stabil-
ity, nuclear localization and transactivation. However, the
regulation of the HIF-1K stability via the ubiquitin^protea-
some pathway appears to be the most important regulatory
mechanism. In normoxia, oxygen-dependent prolyl hydroxy-
lases catalyze modi¢cations of HIF-1K, that allow the von
Hippel^Lindau tumor suppressor protein to bind HIF-1K
and target it for ubiquitination and proteasomal degradation,
whereas under hypoxic conditions this degradation is blocked
([4] ; reviewed in [3]). In addition, abrogation of asparagine
hydroxylation of the C-terminal HIF-1K transactivation do-
main has been shown to be required for the interaction of
HIF-1K with the co-activator p300 and is therefore a prereq-
uisite for full induction of HIF-1K [5].
In human cancers, adaptation to hypoxia appears to be a
critical step in tumor progression to a more malignant stage.
After tumors reach the size of several millimeters in diameter,
di¡usion is not su⁄cient to supply oxygen into the center of
the tumor, thus resulting in a hypoxic condition. Overexpres-
sion of HIF-1K has been detected in tumor cells where it may
mediate adaptive responses to hypoxia, critical to tumor pro-
gression. For example, hypoxia induces vascular endothelial
growth factor in tumors, thus enabling them to establish a
vascular supply that allows them to grow beyond the volume
at which O2 becomes di¡usion-limited. Another essential
adaptation of tumor cells to hypoxia is an increased rate of
glycolysis by induction of glycolytic enzymes, which allows
energy production in low oxygen conditions. In addition to
intratumoral hypoxia, genetic alterations in tumor suppressor
genes and oncogenes has been shown to result in overexpres-
sion of HIF-1K in tumors [3]. Obviously, genes mediating
adaptive responses to hypoxia play important roles in tumor
development. With this in mind, we set out to look for novel
hypoxia-inducible genes in human cell lines using representa-
tional di¡erence analysis (RDA).
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2. Materials and methods
2.1. Cells and cell culture
HepG2 (human hepatocellular carcinoma) and MCF-7 (human
mammary adenocarcinoma) cell lines were obtained from the Amer-
ican Type Culture Collection (Manassas, VA, USA). A mutant strain
of the mouse hepatoma cell line Hepa1c1c7 (Hepa-1) de¢cient in
ARNT (c4) was previously constructed in this laboratory [6]. All of
the cell lines were cultured in nucleoside-free K-minimal essential me-
dium (Life Technologies, Rockville, MD, USA) supplemented with
10% fetal calf serum (Omega, Tarzana, CA, USA), 100 U/ml of pen-
icillin and streptomycin (Gemini Bio-Products, Woodland, CA, USA),
and 0.25 U/ml of amphotericin (Omega). The hypoxic treatment was
performed in a sealed incubation chamber (Billups-Rothenburg, Del
Mar, CA, USA) £ushed with a gas mixture containing 1% oxygen, 5%
carbon dioxide and 94% nitrogen. The cells were exposed to hypoxia
at 90% con£uency. Fresh medium was exchanged immediately prior
to hypoxia exposure since many hypoxia-inducible genes are also
induced by hypoglycemia [7].
2.2. RDA
HepG2 and MCF-7 cells were exposed to either normoxia or hyp-
oxia (1% oxygen) for 16 h. Messenger RNA was isolated using the
Fast Track 2.0 mRNA isolation kit according to the manufacturer’s
instructions (Invitrogen, Carlsbad, CA, USA). Double-stranded
cDNA populations were synthesized from mRNA using standard
techniques. RDA was performed as described previously [8]. Brie£y,
amplicons representing the hypoxia-treated (tester) and control (driv-
er) cDNA fragments were ¢rst created from the cDNA populations.
To accomplish this, the cDNAs were digested with the restriction
enzyme Dpn II. Identical adaptors were then placed on both ends
of both cDNA populations and the adaptor-ligated cDNA fragments
were ampli¢ed using additional unliganded adaptors as polymerase
chain reaction (PCR) primers to create amplicons. All adaptors
were then removed from both amplicon species and new adaptors
were ligated onto only the tester amplicons. To enrich the tester am-
plicons with upregulated gene fragments, subtractive cross-hybridiza-
tion of tester and driver amplicons was performed. During this phase,
a great excess of adaptor-less driver amplicons was hybridized to test-
er amplicons, followed by PCR ampli¢cation of the hybridization
mxiture using adaptors speci¢c for the tester amplicons as primers.
The resultant di¡erence product was then cleaved again with Dpn II
and a new adaptor sequence placed at the ends. The original adaptor-
less driver amplicons were again used with this new ‘tester’ species in
the next subtractive hybridization/PCR reaction. This cycle was then
repeated three additional times with fresh adaptors placed on the
resultant di¡erence product each time. After four cycles of subtractive
hybridization/PCR ampli¢cation, the di¡erence product was cloned
into the pTarget vector (Promega, Madison, WI, USA) using the
T/A overhang technique. Clones were con¢rmed for induction by
hypoxia using a modi¢ed reverse Northern technique whereby the
inserts were immobilized on duplicate nitrocellulose membranes and
probed with normalized [32P]dATP-labeled (Prime-A-Gene Labeling
kit, Promega) amplicons from hypoxia-treated or untreated cells. The
induction of upregulated clones was con¢rmed by Northern analysis
and they were then sequenced using an Applied Biosystems PRISM
cycle sequencing system (Laragen, Santa Monica, CA, USA). Identi-
¢cation of the isolated cDNA fragments was established by BLAST
searches of the NCBI Databank.
Fig. 1. Hypoxic induction of mRNAs for the cloned genes in MCF-7 (Fig. 1A) and HepG2 (Fig. 1B) cell lines. The cells were exposed to 1%
O2 for the times indicated. Constitutively expressed ChoB was used to correct for inter-lane variability. The results of phosphor-imager analysis
of band intensities are presented. (For the MCF-1 cell line, data for the longer transcript were used for tuftelin and data for the shorter tran-
script for DEC1.)
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2.3. Northern analysis
Cells were exposed to normoxia or hypoxia for the periods indi-
cated. mRNA was isolated using the Fast Track 2.0 mRNA isolation
kit according to the manufacturer’s instructions (Invitrogen). North-
ern blotting was performed according to standard protocols. Labeling
of the probes was done by random primed [32P]dATP incorporation
(Prime-A-Gene Labeling kit, Promega). Phosphor-imaging analysis
was performed on a Molecular Dynamics 455SI phosphorimager
with correction for inter-lane load variability by comparison with
ChoB (Chinese hamster ovary B), a constitutively expressed gene
that is not responsive to hypoxia. ChoB cDNA was kindly provided
by Dr. Harvey Herschman.
2.4. Western analysis
Cells were exposed to normoxia or hypoxia for 48 h or for the
periods indicated. At harvest, cells were scraped, resuspended in phos-
phate-bu¡ered saline and pelletted by centrifugation at 5Ug for 5 min
at 4‡C. The pellets were then suspended in SDS^PAGE sample bu¡er
(10% sodium dodecyl sulfate (SDS), 0.5 m Tris^HCl pH 6.8, 2.5 mM
ethylenediamine tetraacetic acid (EDTA), 47% glycerol, 0.5% bromo-
phenol blue, non-reducing), vortexed and sonicated for three 1 s in-
tervals. 24 Wg of each sample was reduced by boiling in the presence
of 0.1% L-mercaptoethanol and separated by SDS^PAGE in 10%
polyacrylamide gels. Proteins were immobilized onto Immobilon-P
Western membrane (Millipore, Bedford, MA, USA), and probed
with primary antibodies to DEC1 (di¡erentiated embryo chondrocyte
1; Chemi-Con International, Temecula, CA, USA), tuftelin [9] and
MIG-6 (mitogen-inducible gene 6, kindly provided by Dr. A. Mak-
kinje). Membranes were then incubated with secondary antibody con-
sisting of either goat anti-mouse IgG (MIG-6) or goat anti-rabbit IgG
(tuftelin, DEC1) conjugated to horseradish peroxidase in blotto at
1:2000 dilution for 1 h at room temperature. Proteins were detected
with Super Signal West Pico Chemiluminescent Substrate (Pierce,
Rockford, IL, USA) on Kodak BioMax MR ¢lm.
2.5. CoCl2 treatment of mice
Treatment of the mice with CoCl2, a chemical known to mimic
physiological hypoxia in animals [10], was performed by intraperito-
neal injection of C57BL/6 mice with 75 mg/kg of CoCl2 or vehicle
(saline). Mice were killed 10 h later and organs harvested and stored
in liquid nitrogen.
3. Results
3.1. Identi¢cation of clones representing hypoxia-inducible
genes
RDA experiments performed on the human hepatocellular
carcinoma (HepG2) or the human mammary adenocarcinoma
(MCF-7) cell lines comparing cDNAs from untreated cells
and from cells treated for 16 h with 1% O2, lead to the iso-
lation of several clones that were con¢rmed to be hypoxia-
inducible by reverse Northern analysis. As expected, many of
these clones represented previously identi¢ed hypoxia-induc-
ible genes, including heme-oxygenase 1, enolase 1, lactate de-
hydrogenase A, plasminogen activator inhibitor 1, alpha-1-
antitrypsin and hexokinase 2. From the RDA experiment
with MCF-7 cells, hypoxia-inducible clones representing
cDNAs for tuftelin and DEC1 (di¡erentiated embryo chon-
drocyte 1; also known as Stra13 and Sharp-2) were also iso-
lated (Fig. 1A). During the course of this work DEC1 was
identi¢ed by other investigators as well as ourselves as being
hypoxia-inducible [11^13]. From the HepG2 cell line we iden-
ti¢ed two genes, MIG-6 (also called gene 33) and adipophilin,
Fig. 2. Hypoxic induction of MIG-6 (A), tuftelin (B) and DEC1 (C)
proteins in MCF-7 and HepG2 cells. Cells were exposed to 1% O2
for the times indicated.
Fig. 3. Induction of MIG-6, adipophilin and DEC1 mRNAs in liv-
ers of mice treated with intraperitoneal injection of 75 mg/kg of
CoCl2 or vehicle (saline) for 10 h. ChoB mRNA was used to con-
trol for loading.
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that showed strong hypoxic responses and that were previ-
ously not known to be hypoxia-inducible (Fig. 1B).
3.2. Characterization of hypoxic induction
MIG-6, adipophilin, tuftelin and DEC1 were responsive to
hypoxia in both MCF-7 and HepG2 cell lines (Fig. 1). Time-
course experiments revealed a time-dependent upregulation of
mRNA expression of all of the genes in both the HepG2 and
MCF-7 cell lines, with maximal inductions at the longest time
point studied, i.e. 24 h (Fig. 1). The maximal inductions of
tuftelin and of DEC1 mRNAs were relatively similar in both
cell lines, ranging in di¡erent experiments from 6.5-fold to
nine-fold for tuftelin and from four- to six-fold for DEC1.
MIG-6 showed more inter-experimental variation and the in-
duction appeared to be stronger in MCF-7 cells compared to
HepG2 cells (maximal fold inductions were seven- to 17-fold
and two- to 12-fold, respectively). Adipophilin showed six- to
seven-fold induction in HepG2, and the induction was more
marked and variable in MCF-7 cell line (10- to 70-fold). The
variations in inducibility, particularly for MIG-6 and adipo-
philin mRNAs in MCF-7 cells, are probably due to the di⁄-
culties in accurately detecting the very low levels of these
mRNAs in normoxic cells.
Western blotting analyses showed that MIG-6, tuftelin and
DEC1 were inducible also at the protein level (Fig. 2). (We
could not detect the adipophilin protein with available anti-
bodies.)
DEC1, MIG-6 and adipophilin mRNAs were also observed
to be inducible in livers of mice treated with CoCl2, a chem-
ical known to mimic physiological hypoxia in animals [10]
(Fig. 3). MIG-6, adipophilin and DEC1 were also inducible
by hypoxia in the mouse hepatoma cell line, Hepa-1, but did
not respond to hypoxia in an ARNT-de¢cient derivative of
Hepa-1 cells (Fig. 4). This demonstrates that the hypoxic in-
duction of these genes is dependent on ARNT and therefore
on HIF-1.
4. Discussion
In the present study we identi¢ed three novel hypoxia-re-
sponsive genes: MIG-6, adipophilin and tuftelin. A fourth
gene, DEC1, was also identi¢ed; its hypoxic induction has
recently been published by us [11] and others [12,13]. The
genes identi¢ed encode a spectrum of proteins with diverse
cellular functions. MIG-6 mRNA levels have been found to
increase sharply in response to various mitogens and com-
monly occurring chronic stress stimuli [14,15]. The rapid
stress-induced expression of MIG-6 suggests that it is an im-
mediate early gene that may serve to reprogram cells in order
to enable them to respond to persistent stress. Indeed, MIG-6
has recently been shown to activate stress-activated protein
kinases (SAPKs). SAPKs in turn stimulate MIG-6 transcrip-
tion and this positive feedback cycle thus maintains chronic
activation of SAPK-dependent mechanisms [14]. MIG-6 con-
tains several SH2 domains, which indicate that it may be an
adaptor protein that binds monomeric GTPases. Our results
indicate that in addition to acting as a mediator for previously
known cell stressors, MIG-6 may also act as an adaptor mol-
ecule in mediating signal transduction in the cellular responses
to hypoxia. Given its widespread tissue distribution, MIG-6
may have a relatively universal function in the body [16].
Adipophilin is expressed at the surface of lipid droplets in
many di¡erent cell types and tissues that accumulate lipids,
such as lactating mammary epithelial cells, adrenal cortex cells
and hepatocytes [17]. Adipophilin may thus have a general
role in deposition and turnover of lipids. Adipophilin has
recently been found to be upregulated in renal cell carcinoma
[18]. Interestingly, it has been shown that activation of AhR,
another dimerization partner for ARNT in addition to HIF-
1K, inhibits adipose di¡erentiation [19]. AHR ligands (e.g.
dioxin) and hypoxia may thus exert opposite e¡ects on adi-
pocyte di¡erentiation via competition for the common factor,
ARNT.
Tuftelin is known to play an important role during the
development and mineralization of enamel in the teeth [20].
Tuftelin is, however, also expressed in many tissues other than
teeth, including kidney, lung and testis in the mouse [20,21],
suggesting that the protein may have a more general physio-
logical role yet to be determined. Therefore, it is interesting
that tuftelin expression is induced by cellular oxygen depriva-
tion.
We show here that induction of DEC1 is dependent on
ARNT, in addition to HIF-1K [12]. DEC1 belongs to the
bHLH family of transcription factors that play important
roles in the regulation of cell proliferation, di¡erentiation,
and apoptosis. The protein has been shown to repress acti-
vated transcription via interactions with the general factors of
the basal transcription machinery [22]. DEC1 has been ob-
served to be upregulated in a large variety of common tumors
[13]. As a transcriptional regulator involved in di¡erentiation
and cell cycle regulation, DEC1 may play a critical role in
carcinogenesis.
In conclusion, we report here identi¢cation of three novel
hypoxia-inducible genes: MIG-6 (gene 33), adipophilin and
tuftelin. Our experiments show that the hypoxic inductions
are dependent on ARNT (HIF-1) and occur also in vivo in
mice under hypoxia-mimicking conditions. Low oxygen levels
elicit a broad spectrum of cellular responses that are crucial
for physiologic homeostasis and may be involved in patholog-
ical conditions. Therefore, searching for the potential roles of
these novel hypoxia-inducible genes in physiological adapta-
tion to hypoxia and in pathways involved in tumorigenesis
will be of considerable interest.
Fig. 4. Hypoxic induction of MIG-6, adipophilin and DEC1
mRNAs in wild-type (wt) Hepa-1 cell line and in a mutant Hepa-1
cell line de¢cient in expression of ARNT (c4) after 16 h exposure to
1% O2. ChoB was used as a load control.
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